Cardiovascular disorder is the leading cause of death worldwide. In India cardiovascular diseases progression is very high and leading cause of mortality. DU is an essential tool for making the health policies and to check the rationality of prescriptions in CVS diseases. DU study also useful to assessment of how drug utilization relates to the effect of drug use, beneficial or adverse. This was observational, prospective, cross-sectional study. Study was conducted at the cardiac OPD, IPD of Private Hospital, Nashik, Maharashtra. Total 100 subjects enrolled in this study. Case Record form filled with the help of prescribed drugs & interview of subjects. Core indicators also studied. DU 90% achieved by drugs Aspirin 39.58%, Clopidogrel 19.5%, Pantoprazole 6.12%, Frusemide 5.44%, Rosuvastatin 4.75%, Atenolol 4.34%, Glyceryl Trinitrate 4.14%, Atorvastatin 4.08%, Chlorthalidone 1.56%, Spiranolactone 1.51%. Average no. of drug per prescription was 4.93, Percentage of drug prescribed by generic name was 0%, 59.37% drugs prescribed from essential drug list. Percentage of antibiotic prescribed was 24%, and percentage of injections prescribed was 22%. Patient care indicator and prescribing indicator should be given importance. The present study found that there were substantial increased in both the utilization of and expenditure for cardiovascular drugs. In this study the incidence of poly pharmacy was high. Trade names were used more often when compared to generic names. Overall, awareness among the physician should be get increased by doing DU studies to make health care society more responsible and satisfies the priority health care needs of population.
Cite this article:
Avinash Khairnar, Supriya Jamdade. Prospective Cross-Sectional Observational Study on Evaluation of Drug Utilization 90% Study in Cardiovascular Diseases. Research J. Pharm. and Tech. 7(9): Sept. 2014 Page 981-986.
Avinash Khairnar, Supriya Jamdade. Prospective Cross-Sectional Observational Study on Evaluation of Drug Utilization 90% Study in Cardiovascular Diseases. Research J. Pharm. and Tech. 7(9): Sept. 2014 Page 981-986. Available on: https://rjptonline.org/AbstractView.aspx?PID=2014-7-9-23